Do you offer adjuvant therapy for localized medullary carcinoma of the ascending colon that is MSI-H?
Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?
Answer from: Medical Oncologist at Community Practice
Medullary carcinoma of the colon is a rare type of colon cancer with unique clinical and molecular features. Despite its high-grade histology, its prognosis is generally better than adenocarcinoma. They tend to be locally advanced and rarely metastasize. They are usually MSI-H with a high number of ...
Comments
Medical Oncologist at University Of Wisconsin Department Of Medicine Thank you, Dr. @Anita Turk. I have a similar situa...
Medical Oncologist at St Louis Cancer Care LLP I have a patient in her late 80s with one positive...
Thank you, Dr. @Anita Turk. I have a similar situa...
I have a patient in her late 80s with one positive...